Compare Hims and Hers Health Inc (HIMS) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Skyworks Solutions Inc — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while Skyworks Solutions Inc trades at $76.35 (market cap $12.15B). The key difference: Skyworks Solutions Inc is the larger of the two by market cap, and Skyworks Solutions Inc pays a 4.13% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Skyworks Solutions Inc for 50 Days on average.
| HIMS | SWKS | |
|---|---|---|
Market Cap | $6.55B | $12.15B |
Volume | 14,842,814 | 7,390,810 |
Sector | Health | Technology |
52-Week High | $62.76 | $91.45 |
52-Week Low | $14.52 | $52.50 |
Typical Hold Time | 21 Days | 50 Days |
Enterprise Value | $7.25B | $12.03B |
Dividend Yield | — | 4.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $28.06, down 5.01% on the day, amid a bearish technical signal and negative earnings surprises. The company reported a net loss of $142 million in 2026, with a negative net income margin of -5.51%, despite revenue growth to $2.6 billion. Multiple securities class action lawsuits filed in October 2026 create significant legal overhang, while analyst consensus remains mixed with a $32.17 price target but only 35% buy ratings.
The outlook is clouded by profitability challenges and legal risks, though revenue growth offers a potential catalyst if margins improve. Investors face substantial downside risk from ongoing litigation and weak earnings, offset by analyst price targets suggesting modest upside from current levels if operational execution improves.
Skyworks Solutions (SWKS) trades at $80.75, down 3.21% today, with a bearish technical signal despite recent earnings beats. The company shows declining revenue and profit margins but maintains positive cash flow from operations. The pending Qorvo merger represents a significant strategic move, with regulatory clearances obtained and expected $500M in synergies. Valuation metrics include a P/E of 41.84 and P/S of 3.03, while analyst consensus leans bullish with 60% buy ratings.
The investment outlook balances merger synergies against fundamental deterioration. Near-term catalysts include the Qorvo deal closure and potential market share gains, but risks include integration challenges and ongoing margin pressure. The stock trades near analyst consensus targets, suggesting limited upside from current levels without operational improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
